Amante Chiara, Esposito Tiziana, Luccheo Gianni, Luccheo Luigi, Russo Paola, Del Gaudio Pasquale
Department of Pharmacy, University of Salerno, via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
Laboratori Nutriphyt s.r.l., via Rosario Livatino, 84083 Castel San Giorgio, Italy.
Life (Basel). 2022 Jul 30;12(8):1162. doi: 10.3390/life12081162.
Cardiovascular disease (CVD) is considered one of the major causes of mortality worldwide. Epidemiological studies have shown that regular consumption of phenols is inversely associated with cardiovascular disease, and the use of nutraceuticals and functional foods can provide protective, preventive, and possibly curative effects in CVD. A novel mixture of different natural substances named Recapsoma (bergamot, liposomal berberine, Ipomoea batatas, oleuropein, polycosanols, and vitamin E) has been produced, and its anti-dyslipidaemic efficacy has been tested, specifically studying the in vitro effects on the mechanisms of action underlying cholesterol synthesis, triglycerides, and LDL-cholesterol oxidation. The work has demonstrated the ability of this herbal extract mixture to inhibit the action of PCSK, ACAT, PAP, and HMGR and to increase the LDL receptor (LDLR), underlying the synergistic effect of the mixture over the single components. Such results suggest that the Recapsoma mixture could be used as a tool for controlling hypercholesterolemia, and an alternative to statins, especially for those patients with metabolic syndrome.
心血管疾病(CVD)被认为是全球主要的死亡原因之一。流行病学研究表明,经常食用酚类物质与心血管疾病呈负相关,使用营养保健品和功能性食品可以对心血管疾病产生保护、预防甚至可能的治疗作用。一种名为Recapsoma的新型不同天然物质混合物(佛手柑、脂质体黄连素、甘薯、橄榄苦苷、多元醇和维生素E)已经研制出来,并对其抗血脂异常功效进行了测试,具体研究了其对胆固醇合成、甘油三酯和低密度脂蛋白胆固醇氧化作用机制的体外影响。这项研究证明了这种草药提取物混合物能够抑制前蛋白转化酶枯草溶菌素/kexin 9型(PCSK)、酰基辅酶A胆固醇酰基转移酶(ACAT)、磷脂酸磷酸酶(PAP)和3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)的作用,并增加低密度脂蛋白受体(LDLR),这表明该混合物相对于单一成分具有协同作用。这些结果表明,Recapsoma混合物可作为控制高胆固醇血症的一种手段,是他汀类药物的替代品,尤其适用于代谢综合征患者。